Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Frédérique Sablier-Gallis"'
Autor:
Meriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu, Mayra Ponce, Caroline Truntzer, Romain Boidot, Clément Le Bescop, Thomas Loppinet, Tanguy Corbel, Céline Féger, Karine Bertrand, Arielle Elkrief, Morten Isaksen, Fabien Vitry, Frédérique Sablier-Gallis, Antoine Andremont, Lloyd Bod, François Ghiringhelli, Jean de Gunzburg, Bertrand Routy
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract The deleterious impact of antibiotics (ATB) on the microbiome negatively influences immune checkpoint inhibitors (ICI) response in patients with cancer. We conducted a randomized phase I study (EudraCT:2019-A00240-57) with 148 healthy volunt
Externí odkaz:
https://doaj.org/article/654c4f9e81204f8999feefb9a049aabe
Autor:
Meriem Messaoudene, Nathalie Saint-Lu, Frédérique Sablier-Gallis, Stéphanie Ferreira, Mayra Ponce, Clément Le Bescop, Thomas Loppinet, Tanguy Corbel, Céline Féger, Fabien Vitry, Antoine Andremont, Jean de Gunzburg, Bertrand Routy
Publikováno v:
Cancer Research. 83:5882-5882
Background: Over the last decade, studies unraveled the cancer-immune dialogue in the setting of immune checkpoint inhibitors (ICI) and influenced by the gut microbiota. The first evidence of the key role of the microbiota in ICI modulation was obser
Autor:
Caroline H. Chilton, Emma L. Best, Mark H. Wilcox, Jean de Gunzburg, Frédérique Sablier-Gallis, Nathalie Saint-Lu, Charmaine Normington, Hannah C Harris, Antoine Andremont
Publikováno v:
Antimicrob Agents Chemother
A healthy, intact gut microbiota is often resistant to colonization by gastrointestinal pathogens. During periods of dysbiosis, however, organisms such as Clostridioides difficile can thrive. We describe an optimized in vitro colonization resistance
DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones
Autor:
Nathalie Saint-Lu, Charles Burdet, Frédérique Sablier-Gallis, Tanguy Corbel, Agathe Nevière, Sakina Sayah-Jeanne, Mark Pulse, William Weiss, Stéphanie Ferreira, Antoine Andremont, France Mentré, Jean de Gunzburg
Publikováno v:
Antimicrob Agents Chemother
Fluoroquinolone treatments induce dysbiosis of the intestinal microbiota, resulting in loss of resistance to colonization by exogenous bacteria such as Clostridioides difficile that may cause severe diarrhea in humans and lethal infection in hamsters
Autor:
Charles Burdet, Maria J G T Vehreschild, Gérald Glupczynski, Oliver A. Cornely, Leen Timbermont, Aaron Dane, Lena M Biehl, Jean de Gunzburg, Antoine Andremont, Mark H. Wilcox, Frédérique Sablier-Gallis, Marlieke E. A. de Kraker, Cornelis H. van Werkhoven, Marc J. M. Bonten, Elodie Pfender, Renaud Buffet, Fabien Vitry
Publikováno v:
Blood. 138:4437-4437
Background: Acute Myeloid Leukemia (AML) and high-risk Myelodysplastic Syndrome (MDS) patients frequently receive antibiotics (ABX) for febrile neutropenia (prophylaxis or empirical treatment) or for suspected or documented bacterial infections. ABX
Autor:
Luca Guardabassi, Jean de Gunzburg, Teresa Pires dos Santos, Perrine Hugon, Agathe Nevière, Sakina Sayah-Jeanne, Frédérique Sablier-Gallis, Carmen Espinosa-Gongora, Lisbeth Rem Jessen, Charlotte R. Bjornvad, Peter Damborg, Dereje Dadi Gudeta, Nathalie Saint-Lu, Tanguy Corbel, Ida N. Kieler
Publikováno v:
The Journal of antimicrobial chemotherapy. 75(2)
Background Aminopenicillins with or without a β-lactamase inhibitor are widely used in both human and veterinary medicine. However, little is known about their differential impact on the gut microbiota and development of antimicrobial resistance. Ob
Autor:
Charles Burdet, Sakina Sayah-Jeanne, Thu Thuy Nguyen, Perrine Hugon, Frédérique Sablier-Gallis, Nathalie Saint-Lu, Tanguy Corbel, Stéphanie Ferreira, Mark Pulse, William Weiss, Antoine Andremont, France Mentré, Jean de Gunzburg
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2018, 62 (10), ⟨10.1128/AAC.00925-18⟩
Antimicrobial Agents and Chemotherapy, 2018, 62 (10), ⟨10.1128/AAC.00925-18⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2018, 62 (10), ⟨10.1128/AAC.00925-18⟩
Antimicrobial Agents and Chemotherapy, 2018, 62 (10), ⟨10.1128/AAC.00925-18⟩
BackgroundAntibiotic disruption of the intestinal microbiota favors colonization byClostridium difficile. Using a charcoal-based adsorbent to decrease intestinal antibiotic concentrations, we studied the relationship between antibiotic concentrations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c765d9a6b7de82bebdda0ecca60dd4d4
https://www.hal.inserm.fr/inserm-01920049
https://www.hal.inserm.fr/inserm-01920049
Autor:
Jean de Gunzburg, Violaine Augustin, Amine Ghozlane, Laurence Armand-Lefevre, Xavier Duval, Antoine Andremont, Frédérique Sablier-Gallis, Sean Kennedy, Annie Ducher, Marina Varastet, Loubna Alavoine, Nicolas Pons, Elisabeth Chachaty, Florence Levenez, Charles Burdet, Etienne Ruppé
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
The Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
Journal of Infectious Diseases 4 (217), 628-636. (2018)
Journal of Infectious Diseases, 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
The Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
Journal of Infectious Diseases 4 (217), 628-636. (2018)
In a phase 1 clinical study, coadministration of the adsorbent-based DAV132 product together with the fluoroquinolone antibiotic moxifloxacin, while not affecting the plasma concentrations of the antibiotic, reduced by >99% exposure of the intestinal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72129e0df637086bfb515cf4f8d8b31f
https://hal-pasteur.archives-ouvertes.fr/pasteur-02552147/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-02552147/document
Autor:
F. Mentré, Hugon P, Charles Burdet, A. Andremont, Sakina Sayah-Jeanne, Jean de Gunzburg, Nathalie Saint-Lu, Thu Thuy Nguyen, Frédérique Sablier-Gallis, Ferreira S
Publikováno v:
Open Forum Infectious Diseases
Europe PubMed Central
Europe PubMed Central
Background C. difficile (C diff) infection results from antibiotic-induced changes in colonic microbiota. DAV131A, an oral adsorbent-based product, can sequester antibiotic (AB) residues in the gut and reduce mortality in a hamster model of moxifloxa
Autor:
Cornelis H. van Werkhoven, Annie Ducher, Matilda Berkell, Mohamed Mysara, Christine Lammens, Julian Torre-Cisneros, Jesús Rodríguez-Baño, Delia Herghea, Oliver A. Cornely, Lena M. Biehl, Louis Bernard, M. Angeles Dominguez-Luzon, Sofia Maraki, Olivier Barraud, Maria Nica, Nathalie Jazmati, Frederique Sablier-Gallis, Jean de Gunzburg, France Mentré, Surbhi Malhotra-Kumar, Marc J. M. Bonten, Maria J. G. T. Vehreschild, the ANTICIPATE Study Group
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Here, the authors report the incidence of Clostridioides difficile infection (CDI) and assess potential clinical characteristics and biomarkers to predict CDI in 1,007 patients of 50 years and above receiving newly initiated antibiotic treatment.
Externí odkaz:
https://doaj.org/article/1522f4b91ec546008f82035912919766